Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey
about
Hyperuricaemia with deposition: latest evidence and therapeutic approachHealth-related quality of life in gout: a systematic reviewUpdate on the Clinical Effect of Acupuncture Therapy in Patients with Gouty Arthritis: Systematic Review and Meta-AnalysisThe impact of gout on patient's lives: a study of African-American and Caucasian men and women with gout.Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout.A Systematic Review of the Economic and Humanistic Burden of Gout.Health-related quality of life and treatment satisfaction in patients with gout: results from a cross-sectional study in a managed care setting.A cross-sectional internet-based patient survey of the management strategies for gout.Patient and clinical characteristics associated with gout flares in an integrated healthcare system.Association between Gout and Erectile Dysfunction: A Systematic Review and Meta-Analysis.Physical Function, Hyperuricemia, and Gout in Older Adults."You want to get on with the rest of your life": a qualitative study of health-related quality of life in gout.Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective AnalysisPopulation-specific association between ABCG2 variants and tophaceous disease in people with goutTophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.Trends in physician diagnosed gout and gout therapies in the US: results from the national ambulatory health care surveys 1993 to 2009.The gouty tophus: a review.Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN).Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis.Nocturia Work Productivity and Activity Impairment Compared with Other Common Chronic Diseases.Serum uric acid levels and the risk of flares among gout patients in a US managed care setting.Prevalence and associations of gout and hyperuricaemia: results from an Australian population-based study.Management of gout in the real world: current practice versus guideline recommendations.A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.Gout Self-Management in African-American Veterans: A Qualitative Exploration of Challenges and Solutions from Patients' Perspectives.Racial differences in health-related quality of life and functional ability in patients with gout.Health and Utilities in Patients With Gout Under the Care of a Rheumatologist.Gout and comorbidity: a nominal group study of people with gout.As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout.Associated factors with functional disability and health-related quality of life in Chinese patients with gout: a case-control study.Depression and anxiety correlate with disease-related characteristics and quality of life in Chinese patients with gout: a case-control study.Multiple Tophaceous Gout of Hand with Extensor Tendon Rupture.Health-related quality of life in gout in primary care: Baseline findings from a cohort study.Treat to target in gout.Clinical characteristics of infectious ulceration over tophi in patients with gout.Risk factors for ulceration over tophi in patients with gout.The British Society for Rheumatology Guideline for the Management of Gout.Improving adherence to gout therapy: an expert review.Accuracy of the HumaSensplus point-of-care uric acid meter using capillary blood obtained by fingertip puncture.Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study.
P2860
Q26775759-09280EA0-1E14-4745-964E-DA750DECF94BQ27690739-BF968A1B-6753-467E-BB0A-B3D790F00D0FQ28075602-3E0F8C4B-DAD4-4BE1-9AA9-9E2087702ADBQ34502543-676D2E81-D314-41B8-8ECE-5E927E9476CCQ35073601-45A17939-B5C6-4ECF-955D-ED5E96E91219Q35629910-A5E3727D-FE35-4E15-9915-D36CED180263Q35849062-92F2EBDE-9656-4B3D-8C33-2DC4C4BD4C51Q35941652-7B0815A3-DA7F-4DC1-BDCD-02F196215B6FQ36177440-3AE037BE-B416-4B3D-9642-4D85ADF141ECQ36236512-B352F7B8-2FB8-4F6B-A319-CDC18C2063E2Q36421974-2DD8D2DF-9C06-4A7B-B71A-801D9C919B8DQ36834494-E9109B3E-4132-4D47-87BD-E74C9CA5E382Q37208467-3BCEDA50-806B-4993-B1CB-9703A9C905C1Q37686521-2E7863D1-7EE3-467E-8EA9-54E82C1E95EEQ37690972-62265014-47E8-4EC8-9ABA-9DF74EDA01B9Q37691042-F8537B58-3575-4B57-837B-15521B4B5EAAQ38374318-CC764944-A9B4-4BBC-B2E3-382E2ADDE490Q38644685-19D37903-6812-42E0-BD20-C8EF3488BEE6Q38669137-F50A58B2-3263-4FDA-97E1-5AB60C2E1F3CQ38942866-1E88D0F4-5DCB-4F8E-BAC7-E7EE4706EEE1Q39360995-D24954D3-591E-46B5-823F-1AA24EB13F90Q40109948-7D41AA8F-4E74-45D7-8899-C38D59BB7DB5Q40291328-013E9013-46E3-447E-B60D-3480967D5386Q40311349-9093DCE8-D373-40FF-90B4-68FBDB63D72CQ40366290-095F2801-BBAA-4267-AA91-61042389EE1BQ40405506-FE09510F-A0E9-45A8-A8AB-56EB7EC69A0EQ41553909-CF7898A9-A707-4891-8086-932F3F443492Q41711313-7857A351-73AC-4043-B9E2-8F94EFBFED0DQ45823744-A15719B5-E26C-473B-95F4-484EE223ADA7Q47149944-D5943270-0BC6-47A0-8576-BE2A76BB716CQ47614985-F4DA7DA2-73E4-4DE3-98A8-F1F7E28FDDBAQ49292668-A3C6F6B9-FCE9-4E27-B91C-0AC504DFB755Q49344479-2FA77B40-C3C4-4A8B-9862-4DED2A2A4919Q49616059-AB66CDC9-FD44-408D-9845-DBAA4A177016Q52627425-843949CD-2FD4-4DBB-96C9-FC00CCD92600Q54339363-B6427A83-C1EB-44EE-BDB7-56265F9B2406Q55060116-F985F050-2BCE-47E6-AEFD-17DAE1DC441EQ55220842-71208FE7-C556-4290-B133-378521446EA9Q55262503-6B9736B6-BDFC-4932-99D4-CBE1B13447A3Q55286574-9541FA7F-DD2A-474B-A8DA-1E5946AD1DBD
P2860
Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Tophi and frequent gout flares ...... from a cross-sectional survey
@ast
Tophi and frequent gout flares ...... from a cross-sectional survey
@en
type
label
Tophi and frequent gout flares ...... from a cross-sectional survey
@ast
Tophi and frequent gout flares ...... from a cross-sectional survey
@en
prefLabel
Tophi and frequent gout flares ...... from a cross-sectional survey
@ast
Tophi and frequent gout flares ...... from a cross-sectional survey
@en
P2093
P2860
P356
P1476
Tophi and frequent gout flares ...... from a cross-sectional survey
@en
P2093
Amir Goren
Anna Forsythe
Anne-Kathrin Tausche
Dinesh Khanna
George Nuki
Jeffrey Vietri
Puja P Khanna
P2860
P2888
P356
10.1186/1477-7525-10-117
P577
2012-09-22T00:00:00Z
P5875
P6179
1052129783